Xeomin 200 unit vials
Ended Awarded
- Contract number
- SPE2DR26FQP2Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,462
Award facts
- Contract value 100% obligated
- $49,461.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $49,461.72 to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by November 26, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 vehicle that extends through December 2026 and serves as the company's primary mechanism for supplying pharmaceutical products and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and broader Department of Defense healthcare operations. The company's extensive federal contract portfolio demonstrates capability across diverse therapeutic domains, including specialty medications, vaccines, and medical devices. This specific award for Xeomin reflects the company's role in supporting military medical readiness and healthcare delivery requirements across the federal government's defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQP2Y?
SPE2DR26FQP2Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FQP2Y worth?
The government has obligated $49,462 on SPE2DR26FQP2Y.
Is contract SPE2DR26FQP2Y an order under another contract?
Yes. SPE2DR26FQP2Y is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP2Y competed?
The extent of competition for SPE2DR26FQP2Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award